BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18927246)

  • 1. Emerging biomarkers for the diagnosis and prognosis of prostate cancer.
    Sardana G; Dowell B; Diamandis EP
    Clin Chem; 2008 Dec; 54(12):1951-60. PubMed ID: 18927246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Related biomarkers in the diagnosis of prostate cancer].
    Xu YM; Liu HZ
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):937-40. PubMed ID: 26665686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].
    Mazzola CR; Ghoneim T; Shariat SF
    Prog Urol; 2011 Jan; 21(1):1-10. PubMed ID: 21193139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alternative tests to PSA for prostate cancer diagnosis].
    Defilippi E; Zitella A; Tizzani A
    Urologia; 2011; 78(2):75-81. PubMed ID: 21553390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers for prostatic cancer.
    Castelli T; Cimino S; Magno C; Morgia G
    Front Biosci (Elite Ed); 2010 Jan; 2(2):641-56. PubMed ID: 20036908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-methylacyl-CoA racemase and hepsin as urinary prostate cancer markers.
    Sroka WD; Adamowski M; Słupski P; Siódmiak J; Jarzemski P; Odrowąż-Sypniewska G; Marszałł MP
    Int J Biol Markers; 2015 Nov; 30(4):e401-6. PubMed ID: 25982684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
    Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
    J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PSA and hK2 in the diagnosis of prostate cancer].
    Alapont Alacreu JM; Navarro Rosales S; Budía Alba A; España Furió F; Morera Martínez F; Jiménez Cruz JF
    Actas Urol Esp; 2008 Jun; 32(6):575-88. PubMed ID: 18655340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.
    Zehentner BK; Secrist H; Zhang X; Hayes DC; Ostenson R; Goodman G; Xu J; Kiviat M; Kiviat N; Persing DH; Houghton RL
    Mol Diagn Ther; 2006; 10(6):397-403. PubMed ID: 17154657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.
    Bryant RJ; Sjoberg DD; Vickers AJ; Robinson MC; Kumar R; Marsden L; Davis M; Scardino PT; Donovan J; Neal DE; Lilja H; Hamdy FC
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.
    Vickers AJ; Cronin AM; Roobol MJ; Savage CJ; Peltola M; Pettersson K; Scardino PT; Schröder FH; Lilja H
    Clin Cancer Res; 2010 Jun; 16(12):3232-9. PubMed ID: 20400522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
    Haese A; Graefen M; Palisaar J; Huland E; Huland H
    Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PSA-based parameters].
    Nakashima J
    Nihon Rinsho; 2005 Feb; 63(2):241-6. PubMed ID: 15714973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA and other tissue kallikreins for prostate cancer detection.
    Stephan C; Jung K; Lein M; Diamandis EP
    Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
    Kovács GL
    Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.
    Sreekumar A; Laxman B; Rhodes DR; Bhagavathula S; Harwood J; Giacherio D; Ghosh D; Sanda MG; Rubin MA; Chinnaiyan AM
    J Natl Cancer Inst; 2004 Jun; 96(11):834-43. PubMed ID: 15173267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
    Ulmert D; O'Brien MF; Bjartell AS; Lilja H
    Nat Rev Urol; 2009 Jul; 6(7):384-91. PubMed ID: 19578355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New circulating biomarkers for prostate cancer.
    Bensalah K; Lotan Y; Karam JA; Shariat SF
    Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netrin 1 and Alpha-Methyl Acylcoenzim-A Racemase in diagnosis of prostate cancer.
    Koseoglu E; Tuncel A; Balci M; Kaya O; Aslan Y; Guzel O; Yilmaz FM; Atan A
    Colomb Med (Cali); 2018 Jun; 49(2):164-168. PubMed ID: 30104809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.